Cardiometabolic conditions such as heart attacks, stroke, type 2 diabetes, hypertension amongst others, are leading the causes of death globally, with its prevalence escalating every year. As most of these conditions are considerably attributed to reversible behaviours, there is a big opportunity to remotely prevent and manage the onset of CVDs and also enable regular, ongoing monitoring post diagnosis and treatment to reduce hospitalizations, emergency visits and in-office appointments. 

However, what has been done so far in RPM for cardiometabolic conditions? What are the outcomes? Which is the level of adoption of RPM programs? What are the main drivers both for practitioners and patients to really use these solutions? Is the advanced age of the patients preventing the implementation of RPM systems?